about
The Tyro3 receptor kinase Axl enhances macropinocytosis of Zaire ebolavirusInterferon-γ Inhibits Ebola Virus InfectionCharacterizing functional domains for TIM-mediated enveloped virus entryTIM-family proteins inhibit HIV-1 release.Inhibition of HIV-1 infection by aqueous extracts of Prunella vulgaris LEbola virus entry: a curious and complex series of events.Ebola virus glycoprotein 1: identification of residues important for binding and postbinding eventsInhibition of HIV-1 replication by P-TEFb inhibitors DRB, seliciclib and flavopiridol correlates with release of free P-TEFb from the large, inactive form of the complexThe Role of Conserved N-Linked Glycans on Ebola Virus Glycoprotein 2.Intrapulmonary Versus Nasal Transduction of Murine Airways With GP64-pseudotyped Viral VectorsRole of the phosphatidylserine receptor TIM-1 in enveloped-virus entry.Rho GTPases modulate entry of Ebola virus and vesicular stomatitis virus pseudotyped vectors.Hypericum in infection: Identification of anti-viral and anti-inflammatory constituents.Equine infectious anemia virus entry occurs through clathrin-mediated endocytosis.Evolution of the equine infectious anemia virus long terminal repeat during the alteration of cell tropism.Cellular specificity of HIV-1 replication can be controlled by LTR sequences.Endocytosis and a low-pH step are required for productive entry of equine infectious anemia virus.Vesicular stomatitis virus pseudotyped with Ebola virus glycoprotein serves as a protective, non-infectious vaccine against Ebola virus challenge in mice.Lentiviral Vectors Pseudotyped with Filoviral Glycoproteins.Production of Filovirus Glycoprotein-Pseudotyped Vesicular Stomatitis Virus for Study of Filovirus Entry Mechanisms.Mechanisms of Filovirus Entry.Differences in Glycoprotein Complex Receptor Binding Site Accessibility Prompt Poor Cross-Reactivity of Neutralizing Antibodies between Closely Related Arenaviruses.DH82 cells: a macrophage cell line for the replication and study of equine infectious anemia virus.Cell specificity of the transcription-factor repertoire used by a lentivirus: motifs important for expression of equine infectious anemia virus in nonmonocytic cells.Cellular and viral specificity of equine infectious anemia virus Tat transactivation.Identification of light-independent inhibition of human immunodeficiency virus-1 infection through bioguided fractionation of Hypericum perforatum.Identification of a novel isoform of Cdk9.Enhanced gene expression conferred by stepwise modification of a nonprimate lentiviral vector.TIM-1 Mediates Dystroglycan-Independent Entry of Lassa Virus.The role of mononuclear phagocytes in Ebola virus infectionDrug induced superinfection in HIV and the evolution of drug resistanceIL-4/IL-13 polarization of macrophages enhances Ebola virus glycoprotein-dependent infectionTIM-1 serves as a receptor for Ebola virus in vivo, enhancing viremia and pathogenesisFrontline Science: CD40 signaling restricts RNA virus replication in Mϕs, leading to rapid innate immune control of acute virus infection
P50
Q24305409-D0EBE17F-FF78-4899-9934-6FD7E17D4048Q28550929-D7500B0A-78BF-42C2-AE70-08DE086E1A90Q30409350-859D760C-47F0-478F-BAB9-E1A2CE7F72C1Q34144143-2F7164B8-F66D-484D-9D01-D00C2182CBB9Q34988956-5356D007-966D-44F3-BBA1-6381C901BA7EQ35619456-E2FFBB02-437A-4BF4-805B-0FF1A23DD25CQ35914444-45F456C4-97A1-429F-8602-43D06E5FA3BDQ35940053-BB34E098-EF4E-41C2-B2BB-AF015F5A192BQ36043248-27A58B01-7838-49AA-95C4-E2D23209E291Q36587580-7AB2D6A9-B657-4B1F-858F-E096F948A3DCQ37036794-E763EB6E-8152-403A-9E4A-C557B53BB265Q37355990-E61F655D-2C95-407A-A80C-340790278171Q37415644-8A6DD523-E354-4D39-835D-7A7D87B2818AQ38921402-847B06C1-5D30-4AB5-9C9D-48224216674FQ39227445-8B07A34A-CD0A-4576-8E4F-9505F20EC103Q39389448-796ED23E-D25A-49FA-8FD4-D53851AE660CQ39798238-F6C9C951-7240-474E-8222-0DADCEC9A74AQ40052567-69444822-2CC1-406F-B8F1-520384795C1EQ40054535-16B7383F-9996-480D-A18F-945A8720F274Q40054544-DDEF4D29-7A65-4024-A7DC-D0FE45CC2947Q40164611-B2FD36BC-E2A8-45C3-8FEA-91614F6FF8D1Q40366469-A23EBBC9-70AC-4934-AA70-1F8341243DA8Q40802883-47ABD634-7FF1-4DB3-82F0-00C1678EC63CQ40901715-D7A6980C-C179-4C4F-8C1A-C7EA8F3B576EQ41469540-0DE2965F-E6AF-4095-8E92-CCD96E1CB40EQ42584889-13A80416-8696-4CCB-9256-E77AF36E06AAQ42802816-7ED7C363-71D0-40EE-A88A-86D148ED889BQ45873369-AF982B26-CF22-4A5F-BA15-2E9216B71C1DQ55084398-F280F75D-FA9F-477C-B14F-BEAF5ED39DABQ56535702-11B5DFE2-4806-4C5F-8549-9C8D25C18442Q79908450-14FB6012-D22D-4207-8C3C-571AA081648CQ91878844-C063A89B-7721-4D27-A386-D74416436842Q93046007-F190615D-0682-4E2C-A9B3-00773417D03AQ95645903-A1424CE7-7738-495F-AC93-788CBA4CECF5
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Wendy Maury
@ast
Wendy Maury
@en
Wendy Maury
@es
Wendy Maury
@nl
type
label
Wendy Maury
@ast
Wendy Maury
@en
Wendy Maury
@es
Wendy Maury
@nl
prefLabel
Wendy Maury
@ast
Wendy Maury
@en
Wendy Maury
@es
Wendy Maury
@nl
P106
P1153
6701522258
P31
P496
0000-0002-9892-4484